Congratulations to Dr. Vinay Puduvalli on his newly funded NIH grant entitled “Characterization of Onalespib, A novel long acting Hsp90 inhibitor, as a chemo and radiosensitizer in Adults with Newly Diagnosed Glioblastoma.
Congratulations to Dr. Vinay Puduvalli on his newly funded NIH grant entitled “Characterization of Onalespib, A novel long acting Hsp90 inhibitor, as a chemo and radiosensitizer in Adults with Newly Diagnosed Glioblastoma.